Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
| HCPC | J9255 |
| Short Description | Inj, methotrexate (accord) |
| Long Description | Injection, methotrexate (accord) not therapeutically equivalent to j9250 and j9260, 50 mg |
| Pricing indicator | 51 |
| Coverage code | D |
| ASC payment group code | |
| BETOS2 code | O1E |
| Action code | A |
| Type of service | 1 |
| Effective date | 2024-01-01 |
| Date Added | 2024-01-01 |
Drug Details
-
Methotrexate is used to treat severe psoriasis (a skin disease in which red, scaly patches form on some areas of the body) that cannot be controlled by other treatments. Methotrexate is also used along with rest, physical therapy, and sometimes other medications to treat severe active rheumatoid arthritis (RA; a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) that cannot be controlled by certain other medications. Methotrexate is also used to treat certain types of cancer including cancers that begin in the tissues that form around a fertilized egg in the uterus, breast cancer, lung cancer, certain cancers of the head and neck, certain types of lymphoma, and leukemia (cancer that begins in the white blood cells). Methotrexate is in a class of medications called antimetabolites. Methotrexate treats cancer by slowing the growth of cancer cells. Methotrexate treats psoriasis by slowing the growth of skin cells to stop scales from forming. Methotrexate may treat rheumatoid arthritis by decreasing the activity of the immune system.